Division of Gastroenterology and Hepatology, Indiana University School of Medicine, Indianapolis, IN, United States of America.
Department of Computer and Information Science, Indiana University Purdue University, Indianapolis, IN, United States of America.
Ann Diagn Pathol. 2020 Aug;47:151518. doi: 10.1016/j.anndiagpath.2020.151518. Epub 2020 Apr 12.
Accurate detection and quantification of hepatic fibrosis remain essential for assessing the severity of non-alcoholic fatty liver disease (NAFLD) and its response to therapy in clinical practice and research studies. Our aim was to develop an integrated artificial intelligence-based automated tool to detect and quantify hepatic fibrosis and assess its architectural pattern in NAFLD liver biopsies. Digital images of the trichrome-stained slides of liver biopsies from patients with NAFLD and different severity of fibrosis were used. Two expert liver pathologists semi-quantitatively assessed the severity of fibrosis in these biopsies and using a web applet provided a total of 987 annotations of different fibrosis types for developing, training and testing supervised machine learning models to detect fibrosis. The collagen proportionate area (CPA) was measured and correlated with each of the pathologists semi-quantitative fibrosis scores. Models were created and tested to detect each of six potential fibrosis patterns. There was good to excellent correlation between CPA and the pathologist score of fibrosis stage. The coefficient of determination (R) of automated CPA with the pathologist stages ranged from 0.60 to 0.86. There was considerable overlap in the calculated CPA across different fibrosis stages. For identification of fibrosis patterns, the models areas under the receiver operator curve were 78.6% for detection of periportal fibrosis, 83.3% for pericellular fibrosis, 86.4% for portal fibrosis and >90% for detection of normal fibrosis, bridging fibrosis, and presence of nodule/cirrhosis. In conclusion, an integrated automated tool could accurately quantify hepatic fibrosis and determine its architectural patterns in NAFLD liver biopsies.
准确检测和量化肝纤维化对于评估非酒精性脂肪性肝病 (NAFLD) 的严重程度及其在临床实践和研究中的治疗反应仍然至关重要。我们的目的是开发一种基于人工智能的综合自动化工具,以检测和量化肝纤维化,并评估其在 NAFLD 肝活检中的结构模式。使用了 NAFLD 患者和不同纤维化程度的肝活检三染切片的数字图像。两位专家肝脏病理学家对这些活检中的纤维化严重程度进行了半定量评估,并使用网络小程序共提供了 987 种不同纤维化类型的注释,用于开发、训练和测试监督机器学习模型以检测纤维化。测量了胶原比例面积 (CPA) 并与每位病理学家的半定量纤维化评分相关联。创建并测试了模型以检测六种潜在纤维化模式中的每一种。CPA 与病理学家纤维化分期评分之间存在良好到极好的相关性。自动 CPA 与病理学家分期的决定系数 (R) 范围为 0.60 至 0.86。不同纤维化分期的计算 CPA 之间存在相当大的重叠。对于纤维化模式的识别,模型的接收器操作曲线下面积分别为门脉周围纤维化的 78.6%、细胞周围纤维化的 83.3%、门脉纤维化的 86.4%,以及正常纤维化、桥接纤维化和结节/肝硬化存在的检测>90%。总之,综合自动化工具可以准确地量化 NAFLD 肝活检中的肝纤维化并确定其结构模式。